Propofol US-DMF submitted!
We are very proud to announce that we have submitted the US-DMF for our own-API Propofol to the FDA.
Propofol has long been on the WHO list of essential medicines worldwide and is needed and used in large quantities all around the globe. Especially since the COVID-19 pandemic, it has become clear that supply chain security for such a product is essential.
With the completion of the work on our US-DMF, Midas Pharma GmbH now enables all interested companies worldwide to make use of the active ingredient manufactured in France/Europe by our contract manufacturer La Mesta Chimie Fine. This clearly emphasizes our commitment to the highest quality and to ensuring stable supply chains in pharmaceutical production "made in Europe".
Your Contact
Dr. Matthias Hassemer
Custom Synthesis & Technology Transfer
Head of Product Management
Rheinstr. 49
55218 Ingelheim
Germany